Peripheral ulcerative keratitis: A review of aetiology and management

Roland Hӧllhumer
{"title":"Peripheral ulcerative keratitis: A review of aetiology and management","authors":"Roland Hӧllhumer","doi":"10.4102/aveh.v81i1.697","DOIUrl":null,"url":null,"abstract":"Background: Peripheral ulcerative keratitis (PUK) is a severe inflammatory disease of the peripheral cornea that can be caused by local factors or systemic inflammatory disease.Aim: The purpose of this review is to give an overview of the pathophysiology, aetiology, clinical features, diagnosis, and management of PUK.Method: A PubMed search was conducted using the keywords, ‘peripheral ulcerative keratitis’ and ‘Mooren’s ulcer’.Results: The peripheral cornea has unique characteristics the predispose to the development of PUK. These include fine capillary arcades that allow for deposition of immune complexes and subsequent activation of an inflammatory cascade with corneal melt. Several conditions have been implicated in the aetiology of PUK. The most commonly cited causes are rheumatoid arthritis (RA), granulomatosis with polyangiitis (GPA) and various dermatoses. In patients with RA, PUK usually presents in established disease, whereas in GPA, PUK may be the presenting feature in up to 60% of cases. In RA it heralds the onset of a systemic vasculitis with significant associated morbidity and mortality. The management of PUK follows an individualised stepwise approach. All patients require supportive measures to encourage healing and halt the process of keratolysis. Systemic autoimmune conditions need a systemic corticosteroid as a fast-acting agent to halt the inflammatory process while cytotoxic therapy maintains long term disease control. Failure to achieve disease control with CTT, necessitates the use of a biologic agent.Conclusion: Peripheral ulcerative keratitis is a severe inflammatory disease of the peripheral cornea that needs a thorough diagnostic workup and stepwise management approach.","PeriodicalId":7694,"journal":{"name":"African Vision and Eye Health","volume":"59 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"African Vision and Eye Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4102/aveh.v81i1.697","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Peripheral ulcerative keratitis (PUK) is a severe inflammatory disease of the peripheral cornea that can be caused by local factors or systemic inflammatory disease.Aim: The purpose of this review is to give an overview of the pathophysiology, aetiology, clinical features, diagnosis, and management of PUK.Method: A PubMed search was conducted using the keywords, ‘peripheral ulcerative keratitis’ and ‘Mooren’s ulcer’.Results: The peripheral cornea has unique characteristics the predispose to the development of PUK. These include fine capillary arcades that allow for deposition of immune complexes and subsequent activation of an inflammatory cascade with corneal melt. Several conditions have been implicated in the aetiology of PUK. The most commonly cited causes are rheumatoid arthritis (RA), granulomatosis with polyangiitis (GPA) and various dermatoses. In patients with RA, PUK usually presents in established disease, whereas in GPA, PUK may be the presenting feature in up to 60% of cases. In RA it heralds the onset of a systemic vasculitis with significant associated morbidity and mortality. The management of PUK follows an individualised stepwise approach. All patients require supportive measures to encourage healing and halt the process of keratolysis. Systemic autoimmune conditions need a systemic corticosteroid as a fast-acting agent to halt the inflammatory process while cytotoxic therapy maintains long term disease control. Failure to achieve disease control with CTT, necessitates the use of a biologic agent.Conclusion: Peripheral ulcerative keratitis is a severe inflammatory disease of the peripheral cornea that needs a thorough diagnostic workup and stepwise management approach.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
外周性溃疡性角膜炎:病因和治疗的综述
背景:周围性溃疡性角膜炎(PUK)是一种严重的周围性角膜炎症性疾病,可由局部因素或全身性炎症性疾病引起。目的:本文综述了PUK的病理生理、病因、临床特点、诊断和治疗。方法:用关键词“外周性溃疡性角膜炎”和“Mooren’s溃疡”在PubMed上进行检索。结果:外周角膜有其独特的特点,易发生PUK。这些包括细小的毛细血管拱廊,允许免疫复合物的沉积和随后的炎症级联与角膜融化的激活。几种情况已牵连到PUK的病因学。最常见的原因是类风湿性关节炎(RA),肉芽肿病伴多血管炎(GPA)和各种皮肤病。在RA患者中,PUK通常出现在已确定的疾病中,而在GPA中,PUK可能是高达60%的病例的表现特征。在类风湿性关节炎中,它预示着全身性血管炎的发病,并伴有显著的发病率和死亡率。PUK的管理遵循个性化的逐步方法。所有患者都需要支持性措施来促进愈合和停止角化过程。全身性自身免疫性疾病需要全身性皮质类固醇作为速效药物来停止炎症过程,而细胞毒性治疗维持长期的疾病控制。CTT无法控制疾病,必须使用生物制剂。结论:周围性溃疡性角膜炎是一种严重的周围性角膜炎症性疾病,需要彻底的诊断和逐步的治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
African Vision and Eye Health
African Vision and Eye Health Health Professions-Optometry
CiteScore
1.00
自引率
0.00%
发文量
46
期刊最新文献
Optometrists’ perspectives on speciality programme development in South Africa Pathophysiology of dry eye disease and novel therapeutic agents Impact of spectacle wear on the quality of life of learners with hearing impairment in Ghana Clinical characteristics and associated factors of diabetic retinopathy in Sudanese patients Refractive error accuracy and user perceptions of a smartphone home-based tester
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1